Clinical outcomes of bortezomib-based therapy in Taiwanese patients with multiple myeloma: A nationwide population-based study and a single-institute analysis.
<h4>Purpose</h4>In a retrospective cohort study, we report the current epidemiology of patients with multiple myeloma (MM) and analyze the real-world clinical outcomes of bortezomib-based therapy.<h4>Materials and methods</h4>This retrospective study was mainly designed to ev...
Main Authors: | Wei-Nung Liu, Chao-Feng Chang, Chi-Hsiang Chung, Wu-Chien Chien, Tzu-Chuan Huang, Yi-Ying Wu, Ching-Liang Ho, Jia-Hong Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0222522 |
Similar Items
-
Clinical outcomes of bortezomib-based therapy in myeloma.
by: Faouzi Djebbari, et al.
Published: (2018-01-01) -
Bortezomib in the management of multiple myeloma
by: Jacob P Laubach, et al.
Published: (2009-09-01) -
TREATMENT OF MULTIPLE MYELOMA WITH BORTEZOMIB
by: Veronika Kodre, et al.
Published: (2008-04-01) -
New bortezomib-based combination therapy for elimination of myeloma cells
by: Voll RE, et al.
Published: (2009-02-01) -
The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma.
by: Jingsong He, et al.
Published: (2014-01-01)